
Fineotex Chemical (FCL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.2B
Gross Profit
433.9M
36.22%
Operating Income
192.8M
16.09%
Net Income
201.3M
16.81%
Balance Sheet Metrics
Total Assets
8.1B
Total Liabilities
757.6M
Shareholders Equity
7.4B
Debt to Equity
0.10
Cash Flow Metrics
Revenue & Profitability Trend
Fineotex Chemical Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 5.3B | 5.7B | 5.2B | 3.7B | 2.2B |
Cost of Goods Sold | 3.3B | 3.5B | 3.4B | 2.4B | 1.4B |
Gross Profit | 2.1B | 2.2B | 1.8B | 1.3B | 757.7M |
Gross Margin % | 38.6% | 38.2% | 34.4% | 35.8% | 34.9% |
Operating Expenses | |||||
Research & Development | - | 10.4M | 6.0M | 4.4M | - |
Selling, General & Administrative | - | 133.3M | 124.5M | 194.0M | 102.3M |
Other Operating Expenses | 541.7M | 309.2M | 468.0M | 255.3M | 153.6M |
Total Operating Expenses | 541.7M | 452.8M | 598.5M | 453.7M | 255.8M |
Operating Income | 1.2B | 1.4B | 1.1B | 692.2M | 397.6M |
Operating Margin % | 22.1% | 25.1% | 21.0% | 18.9% | 18.3% |
Non-Operating Items | |||||
Interest Income | - | 19.5M | 10.5M | 9.4M | 15.5M |
Interest Expense | 10.7M | 3.5M | 8.2M | 2.8M | 1.8M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 1.4B | 1.6B | 1.1B | 732.9M | 558.6M |
Income Tax | 320.4M | 365.4M | 252.4M | 164.0M | 113.1M |
Effective Tax Rate % | 22.7% | 23.2% | 22.0% | 22.4% | 20.2% |
Net Income | 1.1B | 1.2B | 895.5M | 568.9M | 445.6M |
Net Margin % | 20.5% | 21.3% | 17.3% | 15.5% | 20.5% |
Key Metrics | |||||
EBITDA | 1.5B | 1.5B | 1.2B | 729.8M | 437.0M |
EPS (Basic) | - | ₹10.82 | ₹7.97 | ₹4.97 | ₹3.83 |
EPS (Diluted) | - | ₹10.82 | ₹7.97 | ₹4.97 | ₹3.83 |
Basic Shares Outstanding | - | 110752947 | 110810289 | 110748420 | 110970630 |
Diluted Shares Outstanding | - | 110752947 | 110810289 | 110748420 | 110970630 |
Income Statement Trend
Fineotex Chemical Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 292.9M | 227.5M | 375.7M | 308.4M | 231.6M |
Short-term Investments | 132.6M | 507.6M | 131.2M | 4.4M | 47.8M |
Accounts Receivable | 1.2B | 1.4B | 1.0B | 1.1B | 826.7M |
Inventory | 644.8M | 501.1M | 472.9M | 595.9M | 287.5M |
Other Current Assets | 183.6M | 89.7M | 77.5M | 129.2M | 1.1M |
Total Current Assets | 2.6B | 2.9B | 2.2B | 2.3B | 1.7B |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.7B | 1.3B | 888.0M | 739.6M | 494.8M |
Goodwill | 122.8M | 122.8M | 122.8M | 122.8M | 122.8M |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 132.5M | 41.4M | 45.0M | -1.0K | 1.0K |
Total Non-Current Assets | 5.5B | 2.6B | 2.0B | 1.1B | 1.0B |
Total Assets | 8.1B | 5.5B | 4.2B | 3.4B | 2.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 567.5M | 728.1M | 473.6M | 587.7M | 368.4M |
Short-term Debt | 2.2M | 51.9M | 72.8M | 19.1M | 34.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 95.1M | 22.6M | 25.0M | 16.8M | 13.6M |
Total Current Liabilities | 671.0M | 894.1M | 638.4M | 680.7M | 496.2M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | - | - |
Deferred Tax Liabilities | 65.6M | 38.6M | 21.2M | 11.2M | 6.7M |
Other Non-Current Liabilities | - | - | - | 1.0K | -1.0K |
Total Non-Current Liabilities | 86.6M | 51.8M | 31.9M | 20.2M | 12.5M |
Total Liabilities | 757.6M | 945.9M | 670.3M | 701.0M | 508.7M |
Equity | |||||
Common Stock | 229.2M | 221.5M | 221.5M | 221.5M | 221.5M |
Retained Earnings | - | 4.3B | 3.1B | 2.3B | 1.8B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 7.4B | 4.5B | 3.6B | 2.7B | 2.2B |
Key Metrics | |||||
Total Debt | 2.2M | 51.9M | 72.8M | 19.1M | 34.8M |
Working Capital | 1.9B | 2.0B | 1.6B | 1.6B | 1.2B |
Balance Sheet Composition
Fineotex Chemical Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.4B | 1.6B | 1.1B | 732.9M | 558.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 492.0K | 2.0M | 2.4M | 429.0K | 0 |
Working Capital Changes | -153.5M | -395.4M | 293.4M | -642.7M | -372.5M |
Operating Cash Flow | 1.0B | 1.0B | 1.4B | 59.4M | 177.9M |
Investing Activities | |||||
Capital Expenditures | -675.8M | -479.0M | -194.3M | -225.1M | -242.1M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -2.1B | -58.0M | -834.2M | - | -102.0M |
Investment Sales | 47.7M | 48.3M | - | 208.4M | 262.8M |
Investing Cash Flow | -2.8B | -488.2M | -1.0B | -17.2M | -81.7M |
Financing Activities | |||||
Share Repurchases | - | - | 0 | 0 | -18.2M |
Dividends Paid | -92.3M | -226.0M | -58.9M | -49.8M | -13.4M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 1.8B | -225.6M | -56.2M | -47.4M | -31.4M |
Free Cash Flow | 17.6M | 494.8M | 878.4M | -91.4M | -150.1M |
Net Change in Cash | 67.3M | 334.1M | 322.5M | -5.1M | 64.9M |
Cash Flow Trend
Fineotex Chemical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
24.51
Forward P/E
17.45
Price to Book
3.63
Price to Sales
5.07
Profitability Ratios
Profit Margin
19.73%
Operating Margin
16.42%
Return on Equity
14.65%
Return on Assets
13.28%
Financial Health
Current Ratio
3.89
Debt to Equity
0.03
Beta
0.38
Per Share Data
EPS (TTM)
₹9.54
Book Value per Share
₹64.46
Revenue per Share
₹46.39
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
fcl | 26.8B | 24.51 | 3.63 | 14.65% | 19.73% | 0.03 |
Asian Paints | 2.5T | 68.75 | 12.75 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.94 | 16.09 | 20.85% | 16.16% | 4.56 |
Tanfac Industries | 46.6B | 48.54 | 14.95 | 32.50% | 15.83% | 13.28 |
Kingfa Science | 46.2B | 30.12 | 6.35 | 20.98% | 8.58% | 5.90 |
Grauer & Weil | 42.1B | 26.73 | 4.48 | 16.73% | 13.35% | 1.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.